Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors in the Treatment of Hypercholesterolemia and other Pathologies

Title
Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors in the Treatment of Hypercholesterolemia and other Pathologies
Authors
Keywords
-
Journal
CURRENT PHARMACEUTICAL DESIGN
Volume 19, Issue 17, Pages 3161-3172
Publisher
Bentham Science Publishers Ltd.
Online
2013-04-08
DOI
10.2174/13816128113199990313

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started